Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors

Table 3

Risk factors for death in patients with Xp11.2 translocation RCC.

	Univariate analysis			Multivariate Cox regression (last step)
	Death	No death		HR (95% CI)
Gender, male ()	4/7	8/17	0.653
Age (year)			0.446
Symptomatic patient ()	4/7	7/17	0.476
Right side ()	4/7	5/17	0.202
Tumor size (cm)			0.626
	5/7	10/17	0.562
	2/7	11/17	0.106
	4/7	3/17	0.053
LDH (U/L)			0.591
Hemoglobin (g/L)			0.317
Fbg (g/L)			0.014	2.954 (1.011-8.629)	0.048
Tumor thrombus of IVC	3/7	2/17	0.088
Lymph node metastasis	5/7	6/17	0.106
Distant metastasis	4/7	2/17	0.020	12.287 (1.083-139.409)	0.043
Radical surgery	4/6	12/16	0.696
Additional treatment
Targeted drug only	1/7	1/17
Surgery only	1/7	7/17
Surgery+interleukin-1	2/7	4/17
Surgery+targeted drug	3/7	5/17

NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; CRP/Alb: C-reactive protein/albumin ratio; Fbg: fibrinogen; LDH: lactic dehydrogenase. For patients who had surgical treatment, .